Spots Global Cancer Trial Database for microrna
Every month we try and update this database with for microrna cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| microRNA of Human Epidermal Growth Factor Receptor 2 （HER2）Positive Patient Treated With Herceptin | NCT02656589 | Breast Cancer | Capecitabine Trastuzumab | 18 Years - | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Treatment Resistance Related With Gene Expression Profile of Diffuse Large B-cell Lymphoma | NCT01606605 | Diffuse Large B... | 15 Years - 90 Years | Samsung Medical Center | ||
| Evaluation of ProALL miRs in Blood Specimen for Prediction of ALL Relapse Risk | NCT03000335 | B-cell Acute Ly... | 2 Years - 19 Years | Curewize Health Ltd. | ||
| Evaluation of MicroRNA Expression in Blood and Cytology for Detecting Barrett's Esophagus and Associated Neoplasia | NCT02464930 | Barrett's Esoph... Gastroesophagea... Esophageal Aden... | 18 Years - | Midwest Veterans' Biomedical Research Foundation | ||
| The Role of SNP rs2910164 in Patients Treated With Immune Checkpoint Inhibitors | NCT04038996 | Cancer | 18 Years - 99 Years | University of Freiburg | ||
| Treatment Resistance Related With Gene Expression Profile of Diffuse Large B-cell Lymphoma | NCT01606605 | Diffuse Large B... | 15 Years - 90 Years | Samsung Medical Center | ||
| Pomegranate Extract Supplementation in Colorectal Cancer Patients | NCT01916239 | Colorectal Canc... | Standard pomegr... Pomegranate ext... Pomegranate ext... | 18 Years - | National Research Council, Spain | |
| Identify microRNAs in Cachexia in Pancreatic Carcinoma | NCT05275075 | Resectable Panc... | Pancreatic canc... | 18 Years - | University of Oklahoma | |
| microRNA in Thyroid Cancer | NCT01964508 | FNA microRNA Thyroid Cancer Thyroid Nodule | Fine needle asp... | 18 Years - 75 Years | Hadassah Medical Organization | |
| Pomegranate Extract Supplementation in Colorectal Cancer Patients | NCT01916239 | Colorectal Canc... | Standard pomegr... Pomegranate ext... Pomegranate ext... | 18 Years - | National Research Council, Spain | |
| miRNA and Relevant Biomarkers of BC Patients Undergoing Neoadjuvant Treatment | NCT03779022 | Breast Cancer | microRNA | 18 Years - 75 Years | Peking University First Hospital | |
| Molecular Mechanisms Leading to Chemoresistance in Epithelial Ovarian Cancer | NCT02758652 | Ovarian Cancer | 18 Years - | Tampere University Hospital | ||
| Discovery of Sirolimus Sensitive Biomarkers in Blood | NCT03304678 | Lymphangioleiom... | Sirolimus 2mg | 18 Years - 90 Years | National Institutes of Health Clinical Center (CC) | |
| A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection | NCT01829971 | Primary Liver C... SCLC Lymphoma Melanoma Multiple Myelom... Renal Cell Carc... NSCLC | MRX34 | 18 Years - | Mirna Therapeutics, Inc. | |
| Plasma microRNA Profiling as First Line Screening Test for Lung Cancer Detection: a Prospective Study | NCT02247453 | Lung Cancer | screening | 50 Years - 75 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Analysis of miRNA Expression in Endometrial Cancer | NCT04845425 | Endometrial Can... | 18 Years - | IRCCS Azienda Ospedaliero-Universitaria di Bologna | ||
| microRNA of Human Epidermal Growth Factor Receptor 2 （HER2）Positive Patient Treated With Herceptin | NCT02656589 | Breast Cancer | Capecitabine Trastuzumab | 18 Years - | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| microRNA Profiles Identification in Adeno Carcinoma Prostate Cancer | NCT02964351 | Prostate Carcin... | High PSA levels | 18 Years - | Assuta Medical Center | |
| The Role of SNP rs2910164 in Patients Treated With Immune Checkpoint Inhibitors | NCT04038996 | Cancer | 18 Years - 99 Years | University of Freiburg | ||
| AI for Lung Cancer Risk Definition in Computed Tomography Screening Programs | NCT06320184 | Lung Cancer Blood Biomarker... | Artificial Inte... | 50 Years - 75 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| SerUm and Plasma MicroRNAs in Malignant Ovarian gERm Cell Tumours | NCT06329323 | Germ Cell Ovari... Germ Cell Tumor Germ Cell Cance... Germ Cell Neopl... Ovary Cancer Ovary Neoplasm Ovarian Cancer Ovarian Neoplas... | Blood test Pathology speci... | 16 Years - | Imperial College London | |
| Effect on Markers of Cardiovascular, Reproductive and Cancer Risk From Firefighting Training | NCT05753254 | Reactive Hypere... Micro RNA Heart Rate Vari... DNA Strand Brea... Oxidative Stres... Heat Stress | Firefighting tr... Firefighting tr... Firefighting tr... | 18 Years - | National Research Centre for the Working Environment, Denmark | |
| Comparison of Multi-parametric and Bi-parametric Magnetic Resonance Imaging in Men With Suspicion of Prostate Cancer | NCT03693703 | Prostatic Neopl... | bi-parametric M... multi-parametri... | 18 Years - 75 Years | Fondazione del Piemonte per l'Oncologia | |
| Expression Levels of RISC and Microprocessor Complex Components in Epithelial Skin Cancer | NCT01345760 | Skin Cancer | 18 Years - | Ruhr University of Bochum | ||
| Evaluation of ProALL miRs in Blood Specimen for Prediction of ALL Relapse Risk | NCT03000335 | B-cell Acute Ly... | 2 Years - 19 Years | Curewize Health Ltd. | ||
| Pomegranate Extract Supplementation in Colorectal Cancer Patients | NCT01916239 | Colorectal Canc... | Standard pomegr... Pomegranate ext... Pomegranate ext... | 18 Years - | National Research Council, Spain | |
| MicroRNA Profiles in Triple Negative Breast Cancer | NCT04771871 | Triple Negative... | Epirubicin Cyclophosphamid... Paclitaxel Carboplatin | 18 Years - 70 Years | University College Hospital, Ibadan | |
| First-in-Human Study of INT-1B3 in Patients With Advanced Solid Tumors | NCT04675996 | Solid Tumor | INT-1B3 | 18 Years - | InteRNA | |
| Lung Cancer Prevention Screening Programme in Italy | NCT05766046 | Lung Cancer COPD (Chronic O... Cardiovascular ... | early lung canc... blood test | 55 Years - 75 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Different Genetic Features Associated With Hepatic Carcinogenesis | NCT01247506 | Hepatocellular ... | 45 Years - 70 Years | National Taiwan University Hospital | ||
| A Combined GWAS and miRNA for the Identification of Bevacizumab Response Predictors in Metastatic Breast Cancer | NCT01598285 | Breast Cancer I... | 18 Years - | Spanish Breast Cancer Research Group | ||
| First-in-Human Study of INT-1B3 in Patients With Advanced Solid Tumors | NCT04675996 | Solid Tumor | INT-1B3 | 18 Years - | InteRNA | |
| The Role of SNP rs2910164 in Patients Treated With Immune Checkpoint Inhibitors | NCT04038996 | Cancer | 18 Years - 99 Years | University of Freiburg | ||
| Predictive and Prognostic Value of Inflammatory Markers and microRNA in Stage IV Colorectal Cancer | NCT04149613 | Colorectal Canc... | 18 Years - | American University of Beirut Medical Center | ||
| Radiofrequency Ablation Combined With S-1 for Pancreatic Cancer With Liver Metastasis | NCT02634502 | Carcinoma, Panc... | radiofrequency ... S-1 | 18 Years - 75 Years | Fudan University | |
| A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection | NCT01829971 | Primary Liver C... SCLC Lymphoma Melanoma Multiple Myelom... Renal Cell Carc... NSCLC | MRX34 | 18 Years - | Mirna Therapeutics, Inc. | |
| Effect on Markers of Cardiovascular, Reproductive and Cancer Risk From Firefighting Training | NCT05753254 | Reactive Hypere... Micro RNA Heart Rate Vari... DNA Strand Brea... Oxidative Stres... Heat Stress | Firefighting tr... Firefighting tr... Firefighting tr... | 18 Years - | National Research Centre for the Working Environment, Denmark | |
| miRNA and Relevant Biomarkers of BC Patients Undergoing Neoadjuvant Treatment | NCT03779022 | Breast Cancer | microRNA | 18 Years - 75 Years | Peking University First Hospital | |
| The Impact Of Tissue Micro-RNA Profile From EUS-FNA In Pancreatic Adenocarcinoma | NCT04765410 | Pancreatic Aden... | EUS FNA (endosc... | 18 Years - | Carol Davila University of Medicine and Pharmacy | |
| MicroRNAs From Blood Samples as Biomarkers for Gastric Cancer Detection | NCT05901376 | Gastric Cancer MicroRNAs | MicroRNA | 18 Years - | King Chulalongkorn Memorial Hospital | |
| Identify microRNAs in Cachexia in Pancreatic Carcinoma | NCT05275075 | Resectable Panc... | Pancreatic canc... | 18 Years - | University of Oklahoma | |
| Analysis of miRNA Expression in Endometrial Cancer | NCT04845425 | Endometrial Can... | 18 Years - | IRCCS Azienda Ospedaliero-Universitaria di Bologna | ||
| Evaluation of MicroRNA Expression in Blood and Cytology for Detecting Barrett's Esophagus and Associated Neoplasia | NCT02464930 | Barrett's Esoph... Gastroesophagea... Esophageal Aden... | 18 Years - | Midwest Veterans' Biomedical Research Foundation |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
